press release archive
Current | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997
Rigel to Present at White Mountain Capital Third Annual Biotechnology Conference on April 19, 2005
South San Francisco, CA - April 14, 2005
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) will present at the White Mountain Capital Third Annual Biotechnology Conference on Tuesday, April 19, 2005 at 11:30 a.m. Eastern Time at The Rihga Royal Hotel in New York. James H. Welch, Rigelís vice president and chief financial officer, will discuss Rigelís clinical development and research programs.
About Rigel (www.rigel.com)
This press release contains "forward-looking" statements, including statements related to Rigel's plans to pursue clinical development of product candidates and the timing thereof and the potential efficacy of product candidates. Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Words such as "plans," "intends," "expects" and similar expressions are intended to identify these forward-looking statements. There are a number of important factors that could cause Rigel's results to differ materially from those indicated by these forward-looking statements, including risks associated with the timing and success of clinical trials and the commercialization of product candidates, as well as other risks detailed from time to time in Rigel's SEC reports, including its Annual Report on Form 10-K for the year ended December 31, 2004. Rigel does not undertake any obligation to update forward-looking statements.
Contact: Jim Welch